← Back to Screener
Incannex Healthcare Limited American Depositary Shares (IXHL)
Price$3.61
Favorite Metrics
Price vs S&P 500 (26W)-75.98%
Price vs S&P 500 (4W)11.65%
Market Capitalization$50.72M
All Metrics
Book Value / Share (Quarterly)$6.13
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)-46.82%
Cash Flow / Share (Quarterly)$-1.54
Price vs S&P 500 (YTD)-68.84%
Gross Margin (TTM)116.40%
Net Profit Margin (TTM)-18137.76%
EPS (TTM)$-18.65
10-Day Avg Trading Volume0.47M
EPS Excl Extra (TTM)$-18.65
Revenue Growth (5Y)-31.02%
EPS (Annual)$-40.83
ROI (Annual)-350.18%
Gross Margin (Annual)48.22%
Net Profit Margin (5Y Avg)-42276.03%
Cash / Share (Quarterly)$5.75
ROA (Last FY)-229.30%
Revenue Growth TTM (YoY)-86.05%
EBITD / Share (TTM)$-7.60
ROE (5Y Avg)-184.95%
Operating Margin (TTM)-21430.61%
Cash Flow / Share (Annual)$-1.93
P/B Ratio0.69x
P/B Ratio (Quarterly)1.69x
Net Income / Employee (Annual)$-4
Net Interest Coverage (TTM)-87.46x
ROA (TTM)-101.90%
EPS Incl Extra (Annual)$-40.83
Current Ratio (Annual)2.86x
Quick Ratio (Quarterly)48.15x
3-Month Avg Trading Volume0.47M
52-Week Price Return-81.38%
Revenue / Employee (TTM)$0
P/S Ratio (Annual)589.82x
Asset Turnover (Annual)0.00x
52-Week High$49.80
Operating Margin (5Y Avg)-56531.83%
EPS Excl Extra (Annual)$-40.83
CapEx CAGR (5Y)72.05%
26-Week Price Return-71.99%
Quick Ratio (Annual)2.82x
13-Week Price Return-69.05%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)48.27x
Enterprise Value$-18.176
Revenue / Share Growth (5Y)25.35%
Asset Turnover (TTM)0.01x
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)2.39x
Pretax Margin (Annual)-54517.44%
Cash / Share (Annual)$2.32
3-Month Return Std Dev164.16%
Net Income / Employee (TTM)$-4
ROE (Last FY)-350.18%
Net Interest Coverage (Annual)-173.19x
EPS Basic Excl Extra (Annual)$-40.83
Receivables Turnover (TTM)4.68x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-18.65
Receivables Turnover (Annual)7.14x
ROI (TTM)-112.39%
P/S Ratio (TTM)517.60x
Pretax Margin (5Y Avg)-42207.34%
Revenue / Share (Annual)$0.07
Price vs S&P 500 (52W)-111.21%
Year-to-Date Return-66.20%
5-Day Price Return26.04%
EPS Normalized (Annual)$-40.83
ROA (5Y Avg)-141.08%
Net Profit Margin (Annual)-54517.44%
Month-to-Date Return21.00%
EBITD / Share (Annual)$-40.15
Operating Margin (Annual)-29373.26%
LT Debt / Equity (Annual)0.00x
ROI (5Y Avg)-184.95%
LT Debt / Equity (Quarterly)2.47x
EPS Basic Excl Extra (TTM)$-18.65
P/B Ratio (Annual)0.47x
Inventory Turnover (TTM)-0.41x
Pretax Margin (TTM)-18107.14%
Book Value / Share (Annual)$2.07
Price vs S&P 500 (13W)-69.74%
Beta1.72x
P/FCF (Annual)145.01x
Revenue / Share (TTM)$0.00
ROE (TTM)-113.31%
52-Week Low$2.40
Industry Peers — Pharmaceuticals(308)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
IXHLIncannex Healthcare Limited American Depositary Shares | 517.60x | -86.05% | 116.40% | — | $3.61 |
LLYEli Lilly & Co. | 13.08x | 44.70% | 83.04% | 27.59% | $903.99 |
JNJJohnson & Johnson | 5.94x | 7.87% | 67.95% | 14.90% | $234.54 |
ABBVABBVIE INC. | 6.04x | 8.57% | 71.62% | -2.88% | $208.99 |
MRKMerck & Co., Inc. | 4.41x | 1.31% | 78.55% | 21.23% | $115.46 |
AZNAstraZeneca PLC | 5.28x | 8.63% | 81.31% | 21.88% | $200.47 |
NVSNovartis AG | 4.98x | 8.91% | 75.82% | 15.26% | $149.73 |
NVONovo-Nordisk A/S | 3.62x | 6.43% | 80.98% | 20.66% | $40.93 |
ABTAbbott Laboratories | 3.66x | 6.59% | 56.50% | 8.20% | $95.47 |
PFEPfizer Inc. | 2.47x | -1.64% | 75.81% | -3.51% | $27.22 |
BMYBristol-Myers Squibb Co. | 2.47x | -0.22% | 72.63% | — | $58.96 |
About
Incannex Healthcare is a clinical-stage pharmaceutical company developing cannabis-based therapeutics for Obstructive Sleep Apnea, Traumatic Brain Injury, Rheumatoid Arthritis, and various inflammatory conditions. The company holds an Australian license to import, export, and distribute medicinal cannabis and has commercialized a cannabinoid product line. Its research and development extends to both cannabis and psychedelic medicine applications.